The President of Venezuela, Nicolas Maduro, has said that he will give the COVAX system an ultimatum this week to send the country's share of COVID-19 vaccines as all pending payments had been made to COVAX, the global vaccine sharing facility, Reuters news agency reported on Monday.
COVAX reportedly informed Venezuela in June 2021 that the last four payments had been blocked by UBS. These payments cover the USD120m fees that have already been made.
Maduro was quoted as saying in a live appearance on state television that officials had been instructed to "give the COVAX system an ultimatum: they send us the vaccines or they give us the money back, period."
Venezuela is facing US sanctions that affect its access to the global financial system and reportedly relied on domestic banks to make part of the payment to the COVAX system with foreign currency.
The country has expressed interest in receiving the Johnson & Johnson (NYSE:JNJ) and Novavax (Nasdaq:NVAX) vaccines through COVAX.
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
4basebio announces strategic collaboration with Genezen
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
Innorna Nominated for 2026 Prix Galien USA Best Startup Award
Sanofi's MenQuadfi receives EU approval for infants from six weeks
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
SK bioscience to lead Gates Foundation-funded ROTOR project
Anixa Biosciences' breast cancer vaccine technology granted first Korean patent
Transgene expands myvac platform into non-small cell lung cancer with TG4070
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB